The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Wade, who turned 43 earlier this month, said his father’s journey with prostate cancer inspired him to see a doctor after ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
Collaboration highlights Healthpoint’s commitment to advancing sports medicine and supporting athletes’ well-being ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Our privacy statements outline how we collect, use, and share different types of personal information and the reasons for doing so. If you have any questions regarding any of our privacy ...
Dwyane Wade recalled how a routine checkup turned into a life-changing cancer diagnosis that forced him to confront his own ...